Home | Welcome to Contract Pharma   
Last Updated Tuesday, June 18 2013
Print RSS Feed

Breaking News

Related Searches:
MorphoSys, Boehringer Sign Manufacturing Pact

March 16, 2011
MorphoSys AG and Boehringer Ingelheim have signed a manufacturing agreement for therapeutic antibodies covering the process development and manufacture of additional clinical material for MorphoSys’s MOR208 program and other drug candidates.  Read More »
Akrimax Launches NitroMist

March 16, 2011
Akrimax Pharmaceuticals has introduced NitroMist (Nitroglycerin Lingual Aerosol) 400mcg/spray indicated for acute relief of an attack or acute prophylaxis of angina pectoris due to coronary artery disease.  Read More »
Almac Adds Walleting for Clinical Trial Supply

March 16, 2011
Almac has invested in two ZED automated inline wallet presses at its Craigavon and Pennsylvania facilities.  Read More »
RegeneRx AMI Trial Placed on Clinical Hold

March 16, 2011
RegeneRx Biopharmaceuticals, Inc. has received a notice from the FDA indicating that, due to non-compliance with cGMP regulations by its contract manufacturer, the company’s Phase II trial of RGN-352 has been placed on clinical hold.  Read More »
Cytovance to Expand Bio-Manufacturing Capabilities

March 15, 2011
Cytovance Biologics has secured financing of $22.5 million from Great Point Partners, LLC to invest in the expansion its biologic manufacturing capabilities in Oklahoma City.  Read More »
Takeda, KINAXO Extend Research Pact

March 15, 2011
KINAXO Biotechnologies GmbH has entered a second collaboration with Takeda Pharmaceutical Co., under which KINAXO will apply its PhosphoScout technology to assist research of Takeda’s drugs under development.   Read More »
Incyte, Novartis Ruxolitinib Trial Shows Promise

March 15, 2011
Incyte Corporation’s COMFORT-II, the second Phase III trial of investigational Janus kinase (JAK) inhibitor, ruxolitinib, has met its primary endpoint of significantly reducing spleen size in patients with myelofibrosis.  Read More »
ClinTec International

March 15, 2011
Dr. Stuart Grant has been promoted to associate director of regulatory affairs and medical writing at ClinTec International.   Read More »
Lilly Bids for J&J Animal Health Biz

March 14, 2011
Elanco, Lilly’s animal health division, has made a one-time offer to acquire the animal health business of Janssen Pharmaceutica NV, a Johnson & Johnson company.   Read More »
PROLOR Biotech Expands R&D Facility

March 14, 2011
PROLOR Biotech, Inc. is relocating its corporate office and R&D facility to a new, larger building located near its current site in the Weizmann Science Park in Nes Ziona, Israel.   Read More »
Catalent

March 14, 2011
Lance Miyamoto has been appointed senior vice president of Human Resources, Catalent Pharma Solutions, Inc.   Read More »
Labopharm

March 14, 2011
Mark D’Souza has been appointed president and chief executive officer of Labopharm and a member of the board of directors.   Read More »
J&J Unit Signs Consent Decree for U.S. Facilities

March 11, 2011
McNeil-PPC, Inc., a Johnson & Johnson subsidiary, has finalized the terms of a Consent Decree with the FDA.   Read More »
FDA Approves Dendreon Expansion

March 11, 2011
Dendreon Corp. received approval from the FDA for the expansion of its NJ manufacturing facility, allowing the company to significantly increase the availability of Provenge.  Read More »
Tolerx, GSK Diabetes Study Misses Endpoint


March 11, 2011
Tolerx and GlaxoSmithKline’s Phase III DEFEND-1 study of otelixizumab, an investigational humanized anti-CD3 monoclonal antibody, did not meet the primary efficacy endpoint in patients with new-onset autoimmune type 1 diabetes.   Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: